AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

HYDROCHLOROTHIAZIDE / VALSARTAN

15 registrations across 3 African markets— 15 active

Markets with HYDROCHLOROTHIAZIDE / VALSARTAN

Recent registrations

Brand / ProductMarketHolderStatusExpires
Co-Diovan tablets
Film Coated Tablets
🇿🇲ZambiaNovartis Pharma ServicesactiveJul 2030
Co-Diovan tablets
Film Coated Tablets
🇿🇲ZambiaNovartis Pharma ServicesactiveJul 2030
VALSAR HT 80/12.5
TABLET, COATED; ORAL
🇿🇼ZimbabweHETERO LABS LTDactiveJun 2028
VALSAR HT 160/25
TABLET, COATED; ORAL
🇿🇼ZimbabweHETERO LABS LTDactiveJun 2028
VALMAC H
TABLET, COATED; ORAL
🇿🇼ZimbabweMACLEODS PHARMACEUTICALS LIMITEDactiveDec 2027
VALMAC H 160
TABLET, COATED; ORAL
🇿🇼ZimbabweMACLEODS PHARMACEUTICALS LIMITEDactiveDec 2027
CO-DIOVAN
TABLET; ORAL
🇿🇼ZimbabweNOVARTIS PHARMA SERVICES AGactiveDec 2027
CO-DIOVAN
TABLET; ORAL
🇿🇼ZimbabweNOVARTIS PHARMA SERVICES AGactiveDec 2027
CO-DOPCOR
comprimé pelliculé / 12,5 mg / 80 mg
🇸🇳SenegalASPEN PHARMACAREactive
STARVAL
comprimé / 12,5 mg / 80 mg
🇸🇳SenegalRANBAXY LABORATOIRES LIMITEDactive
CO-DOPCOR
comprimé pelliculé / 160 mg / 25 mg
🇸🇳SenegalASPEN PHARMACAREactive
VALMAC H
comprimé / 12,5 mg / 80 mg
🇸🇳SenegalMACLEODSactive
VALMAC H PLUS
comprimé / 25 mg / 160 mg
🇸🇳SenegalMACLEODSactive
SAVARAL-HTZ
comprimé / 80mg/12,5mg
🇸🇳SenegalZENECA PHARMAactive
SAVARAL-HTZ
comprimé / B/30
🇸🇳SenegalVIVENZA INTERNATIONALactive

HYDROCHLOROTHIAZIDE / VALSARTAN in Africa — Regulatory Overview

HYDROCHLOROTHIAZIDE / VALSARTAN is registered across 3 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Senegal, Zimbabwe, Zambia. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 15 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.